Nanobiotix (NBTX) Prepaid Assets (2018 - 2025)
Nanobiotix's (NBTX) quarterly Prepaid Assets came in at $9.2 million in Q4 2025, down 2.14% year-on-year from $9.4 million in Q4 2024, and down 12.43% quarter-over-quarter from $10.5 million in Q2 2025.
Nanobiotix (NBTX) Prepaid Assets (2018 - 2025) Analysis & Trends
Nanobiotix's Prepaid Assets history runs 8 years deep, the most recent figure standing at $9.2 million for Q4 2025.
- On a quarterly basis, Prepaid Assets fell 2.14% year-over-year to $9.2 million in Q4 2025; TTM through Dec 2025 was $9.2 million, a 2.14% decrease from a year earlier, with the FY2025 full-year figure at $8.9 million, down 5.02% from the prior year.
- Prepaid Assets eased to $9.2 million in Q4 2025 per NBTX's latest filing, from $10.5 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $16.3 million in Q2 2021 and bottomed at $9.2 million in Q4 2025.
- The 5-year median for Prepaid Assets is $10.5 million (2021), against an average of $11.1 million.
- Across the five-year window, Prepaid Assets jumped 45.3% in 2021 and sank 37.14% in 2022, its largest moves.
- Year by year, Prepaid Assets stood at $10.5 million in 2021, then climbed by 6.06% to $11.1 million in 2022, then slipped by 11.81% to $9.8 million in 2023, then dropped by 4.34% to $9.4 million in 2024, then dropped by 2.14% to $9.2 million in 2025.
- Per Business Quant, the three latest NBTX Prepaid Assets figures stand at $9.2 million (Q4 2025), $10.5 million (Q2 2025), and $9.4 million (Q4 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Alnylam Pharmaceuticals | 36.08 Bn | 33.07 Bn | 959.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 9.15 Mn |
| Jun 30, 2025 | 10.45 Mn |
| Dec 31, 2024 | 9.35 Mn |
| Jun 30, 2024 | 11.85 Mn |
| Dec 31, 2023 | 9.78 Mn |
| Jun 30, 2023 | 11.88 Mn |
| Dec 31, 2022 | 11.09 Mn |
| Jun 30, 2022 | 10.24 Mn |
| Dec 31, 2021 | 10.45 Mn |
| Jun 30, 2021 | 16.30 Mn |
| Dec 31, 2020 | 7.20 Mn |
| Dec 31, 2019 | 12.20 Mn |
| Dec 31, 2018 | 7.33 Mn |